Antidepressive Effect on 5 Herz (Hz) rTMS Over Dorsomedial Prefrontal Cortex and Left Dorsolateral Prefrontal Cortex
Comparative of Antidepressive Effect on 5Hz rTMS on Dorsomedial Prefrontal Cortex and Left Dorsolateral Prefrontal Cortex
1 other identifier
interventional
26
0 countries
N/A
Brief Summary
This study evaluates the efficacy of 5Hz repetitive Transcranial Magnetic Stimulation (rTMS) over Left Dorsolateral Prefrontal Cortex and Dorsomedial Prefrontal Cortex on Major Depressive Disorder (MDD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable major-depressive-disorder
Started Aug 2016
Shorter than P25 for not_applicable major-depressive-disorder
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 8, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2017
CompletedFirst Submitted
Initial submission to the registry
January 10, 2018
CompletedFirst Posted
Study publicly available on registry
June 27, 2018
CompletedApril 16, 2019
April 1, 2019
12 months
January 10, 2018
April 15, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in depressive symptoms evaluated by Hamilton Depressive Rating Scale (HADRS)
Hamilton Depressive Rating Scale (HADRS) is a 21 item clinimetric scale to evaluate severity of depressive symptoms in patients.
3 weeks
Secondary Outcomes (1)
Changes in depressive symptoms evaluated by Montgomery-Asberg Depressive Rating Scale (MADRS)
3 weeks
Study Arms (2)
5Hz Left Dorsolateral Prefrontal Cortex
EXPERIMENTALThis group will receive 5Hz Left Dorsolateral Prefrontal Cortex repetitive Transcranial Magnetic Stimulation. Once a day on monday to friday. Until complete 15 sessions.After complete acute phase intervention (15 sessions) subject will have a 5 week clinical follow up.
5Hz Dorsomedial Prefrontal Cortex
EXPERIMENTALThis group will receive 5Hz Dorsomedial Prefrontal Cortex Transcranial Magnetic Stimulation, once a day on monday to friday. Until complete 15 sessions.After complete acute phase intervention (15 sessions) subject will have a 5 week clinical follow up.
Interventions
Subject will receive 5Hz LDLPFC or 5Hz DMPFC rTMS
Eligibility Criteria
You may qualify if:
- years old.
- Meet DSM 5 (Diagnostic and Statistical Manual, 5 edition) diagnostic criteria for Major Depressive Disorder.
- Score \>17 in Hamilton Depression Rating Scale.
You may not qualify if:
- Subjects with diagnose of Psychotic Depression, Schizophrenia, Bipolar Disorder, Post Traumatic Stress Disorder.
- Subjects with epilepsy or presence of paroxysms during the EEG.
- Subjects with previous history of traumatic brain injury, metal plates in the skull, cochlear devices, infusion devices such as insulin pumps.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Julian Reyes, PhD
Universidad Autónoma de Querétaro
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 10, 2018
First Posted
June 27, 2018
Study Start
August 8, 2016
Primary Completion
July 31, 2017
Study Completion
September 1, 2017
Last Updated
April 16, 2019
Record last verified: 2019-04